MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species

Olga Vera, Carlos Rodríguez‐Antolín, Ana Salgado-Figueroa, Patrycja Michalska, Olga Pernía, Brett M. Reid, Rocío Rosas, Álvaro García-Guede, Silvia Sacristán, Julia Jiménez,

Translational research · 2018 · 36 citations · 34 references

DOIFull text

Open access

Concepts

References

34